"Diltiazem" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzothiazepine derivative with vasodilating action due to its antagonism of the actions of CALCIUM ion on membrane functions.
| Descriptor ID |
D004110
|
| MeSH Number(s) |
D03.633.100.079.150
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Diltiazem".
Below are MeSH descriptors whose meaning is more specific than "Diltiazem".
This graph shows the total number of publications written about "Diltiazem" by people in this website by year, and whether "Diltiazem" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diltiazem" by people in Profiles.
-
Berkenbush M, Sherman N, Jain N, Cosmi P. Prehospital Treatment of Atrial Fibrillation: Infusion Pump for Bolus and Infusion? Prehosp Emerg Care. 2025; 29(1):85-88.
-
Wrishko RE, McCrea JB, Yee KL, Liu W, Panebianco D, Mangin E, Chakravarthy M, Martinez-Cantarin MP, Kraft WK. Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects. Clin Drug Investig. 2019 May; 39(5):441-451.
-
Kaushal G, Sayre BE, Prettyman T. Stability of extemporaneously compounded diltiazem hydrochloride infusions stored in polyolefin bags. Am J Health Syst Pharm. 2013 May 15; 70(10):894-9.
-
Rahman M, Greene T, Phillips RA, Agodoa LY, Bakris GL, Charleston J, Contreras G, Gabbai F, Hiremath L, Jamerson K, Kendrick C, Kusek JW, Lash JP, Lea J, Miller ER, Rostand S, Toto R, Wang X, Wright JT, Appel LJ. A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension. 2013 Jan; 61(1):82-8.
-
Ramdas S, Riesenberg LA, Jasani N. Drug overdose with refractory bradycardia and hypotension. Del Med J. 2011 Jun; 83(6):169-72.
-
Kiernan TJ, Ruggiero NJ, Bernal JM, Don CW, Witzke C, Kiernan GD, Cubeddu RJ, Yan BP. The no-reflow phenomenon in the coronary circulation. Cardiovasc Hematol Agents Med Chem. 2009 Jul; 7(3):181-92.
-
Samuels LE, Holmes EC, Samuels FL. Selective use of amiodarone and early cardioversion for postoperative atrial fibrillation. Ann Thorac Surg. 2005 Jan; 79(1):113-6.
-
Wang HE, O'connor RE, Megargel RE, Schnyder ME, Morrison DM, Barnes TA, Fitzkee A. The use of diltiazem for treating rapid atrial fibrillation in the out-of-hospital setting. Ann Emerg Med. 2001 Jan; 37(1):38-45.
-
Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Pharmacotherapy. 1997 Nov-Dec; 17(6):1238-45.
-
Liu S, Araujo SV, Spaeth GL, Katz LJ, Smith M. Lack of effect of calcium channel blockers on open-angle glaucoma. J Glaucoma. 1996 Jun; 5(3):187-90.